Evidence map›Paper›PMID 32214027›Full record

ReviewCells2020

The FOXO's Advantages of Being a Family: Considerations on Function and Evolution.

Michel Schmitt-Ney

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. PeerJ · 2026
    Article
  3. [Role and mechanisms of FoxO3a-related signaling pathways in breast cancer cell apoptosis].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Forkhead box O proteins: steering the course of stem cell fate.Cell regeneration (London, England) · 2024
    Review
  10. Review
  11. Article
  12. FOXO family isoforms.Cell death & disease · 2023
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Analysis of Promoter Methylation of the BovineAnimals : an open access journal from MDPI · 2023
    Article
  18. Article
  19. FOXOs: masters of the equilibrium.The FEBS journal · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Michel Schmitt-NeyMolecular Biotechnology Center, University of Torino, Via Nizza 52, 10126 Torino, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nematode

Indexed as

Evolution, MolecularAnimalsCaenorhabditis elegansForkhead Transcription FactorsHumansMultigene FamilyForkhead Transcription FactorsagingAKTcancerevolutionforkheadFOXFOXOgene duplicationgene familygenetic redundancyinsulin pathwaymetabolismPI3Ktranscriptiontumor suppressor

Identifiers

PMID32214027
PMCPMC7140813
OpenAlexW3013641498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.